Marianne Davies Discusses Managing Immunotherapy Side Effects
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the challenges of managing side effects from immunotherapy treatments.
Marianne Davies, RN, MSN, ACNP, AOCN, Smilow Cancer Hospital, Yale School of Nursing, discusses the challenges of managing side effects from immunotherapy treatments.
Davies says many of the treatments being developed and tested are immunotherapies. These therapies bring with them a new constellation of possible side effects and symptoms that are very different than the standard chemotherapy side effects nurses are used to.
It is important to educate nurses and primary care physicians, Davies says, but this continues to be a challenge.
Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC
September 11th 2024This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.
